title: [Value of MRI in patients with multiple sclerosis].
abstract: Diagnosis criteria of multiple sclerosis (MS) have been recently reconsidered, introducing the possibility to validate temporal dissemination with the use of MRI. In fact, MRI parameters may be considered as reflecting the biological activity of MS. MRI is used to monitor treatment in clinical trials. However, and except for particular circumstances, its use in routine follow-up of patients with MS is not recommended, because of weak correlations with clinical disability and technical difficulties of such follow-up.
authors.affiliation: Fédération de Neurologie, Hôpital de la Salpêtrière, INSERM U546-Affections de la Myéline et des canaux ioniques musculaires, Faculté de Médecine Pitié-Salpêtrière, Service de Neuroimagerie, CHNO des XV-XX, Paris. ayman.tourbah@psl.ap-hop-paris.fr
authors.forename: A
authors.initials: A
authors.lastname: Tourbah
mesh_terms: D001921:Brain / Q000473:pathology; D002986:Clinical Trials as Topic; D004185:Disability Evaluation; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000628:therapy; D012680:Sensitivity and Specificity
vernacular_title: Intérêt du suivi en IRM des patients atteints de la sclérose en plaques.